HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kunitoshi Mitsumori Selected Research

beta-Naphthoflavone

2/2010Antioxidant enzymatically modified isoquercitrin suppresses the development of liver preneoplastic lesions in rats induced by beta-naphthoflavone.
6/2009Molecular expression analysis of beta-naphthoflavone-induced hepatocellular tumors in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kunitoshi Mitsumori Research Topics

Disease

71Neoplasms (Cancer)
02/2014 - 06/2002
29Carcinogenesis
01/2014 - 01/2002
18Body Weight (Weight, Body)
07/2013 - 04/2002
6Carcinoma (Carcinomatosis)
03/2013 - 05/2006
6Hyperplasia
05/2010 - 12/2002
5Adenoma (Adenomas)
02/2010 - 06/2003
5Hypertrophy
12/2009 - 06/2003
4Hypothyroidism
10/2012 - 12/2009
3Inflammation (Inflammations)
06/2012 - 04/2011
3Hemangiosarcoma (Angiosarcoma)
10/2008 - 07/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2007 - 09/2003
3Lymphoma (Lymphomas)
12/2003 - 12/2002
2Thyroid Neoplasms (Thyroid Cancer)
06/2012 - 01/2012
2IGA Glomerulonephritis (IGA Nephropathy)
06/2012 - 01/2011
2Neuroendocrine Carcinoma
07/2011 - 09/2010
2Adenocarcinoma of Lung
02/2009 - 09/2003
1Chromosomal Instability (Chromosome Stability)
06/2013

Drug/Important Bio-Agent (IBA)

12Drinking WaterIBA
02/2014 - 10/2002
12Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2014 - 08/2004
10Phenobarbital (Luminal)FDA Link
02/2014 - 10/2002
10CarcinogensIBA
06/2013 - 07/2002
8Glutathione Transferase (Glutathione S-Transferase)IBA
09/2012 - 08/2004
7Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2014 - 01/2011
7Piperonyl ButoxideFDA Link
10/2013 - 02/2009
7AntioxidantsIBA
09/2011 - 07/2007
7Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
01/2007 - 06/2002
6diisopropanolnitrosamineIBA
03/2013 - 04/2002
6Reactive Oxygen Species (Oxygen Radicals)IBA
03/2012 - 02/2009
6EnzymesIBA
01/2012 - 12/2008
5indole-3-carbinolIBA
02/2014 - 01/2011
5Proteins (Proteins, Gene)FDA Link
01/2014 - 02/2009
5Thioacetamide (Thioacetamid)IBA
09/2013 - 05/2009
5SulfadimethoxineIBA
03/2013 - 05/2006
5kojic acidIBA
05/2008 - 06/2003
5Phenolphthalein (Modane)IBA
12/2003 - 06/2002
4Hormones (Hormone)IBA
09/2012 - 01/2003
4isoquercitrinIBA
11/2011 - 02/2010
4Messenger RNA (mRNA)IBA
09/2011 - 08/2006
4CytokinesIBA
04/2011 - 05/2010
4dicyclanilIBA
02/2010 - 08/2003
4Urethane (Ethyl Carbamate)IBA
10/2008 - 04/2003
4Ascorbic Acid (Vitamin C)FDA LinkGeneric
08/2008 - 09/2007
3PropylthiouracilFDA Link
03/2013 - 07/2009
3SDMIBA
05/2011 - 05/2006
3oxfendazoleIBA
02/2011 - 05/2009
3benzimidazoleIBA
02/2011 - 05/2009
3AnthelminticsIBA
02/2011 - 05/2009
3Keratins (Keratin)IBA
09/2010 - 02/2010
3FenbendazoleIBA
08/2010 - 05/2009
3Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
05/2010 - 07/2009
3Sodium NitriteIBA
08/2008 - 07/2007
3flumequineIBA
08/2006 - 07/2002
39,10-Dimethyl-1,2-benzanthraceneIBA
01/2005 - 07/2002
2TenascinIBA
03/2013 - 06/2012
2Orphenadrine (Disipal)FDA LinkGeneric
01/2013 - 01/2013
2Methimazole (Thiamazole)FDA LinkGeneric
10/2012 - 07/2010
2Aminobutyrates (Aminobutyric Acid)IBA
10/2012 - 08/2011
2nivalenolIBA
06/2012 - 01/2011
2Carmine (Natural Red 4)IBA
06/2012 - 01/2012
2Immunoglobulin A (IgA)IBA
06/2012 - 01/2011
2VimentinIBA
05/2012 - 06/2010
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
03/2012 - 01/2006
2Flutamide (Eulexin)FDA LinkGeneric
03/2012 - 09/2011
2Omeprazole (Prilosec)FDA LinkGeneric
01/2012 - 01/2012
2Thiobarbituric Acid Reactive SubstancesIBA
01/2012 - 09/2007
2Pharmaceutical PreparationsIBA
01/2012 - 02/2009
2Carbon Tetrachloride (Tetrachloromethane)IBA
08/2011 - 05/2006
2Chromogranin AIBA
07/2011 - 09/2010
2Phosphatidylinositols (Phosphatidylinositol)IBA
05/2011 - 04/2011
2Sphingosine-1-Phosphate ReceptorsIBA
11/2010 - 05/2008
2SilverIBA
09/2010 - 09/2003
2SynaptophysinIBA
09/2010 - 03/2009
2MetalsIBA
05/2010 - 04/2010
2CopperIBA
05/2010 - 07/2009
2Ceruloplasmin (Ferroxidase)IBA
04/2010 - 07/2009
2MetallothioneinIBA
04/2010 - 07/2009
2beta-NaphthoflavoneIBA
02/2010 - 06/2009
2Proliferating Cell Nuclear Antigen (PCNA)IBA
02/2010 - 09/2003
2Troglitazone (Rezulin)FDA Link
10/2008 - 12/2007
2AcidsIBA
08/2008 - 01/2008
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2008 - 01/2008
2OligonucleotidesIBA
12/2007 - 12/2004
2anthraceneIBA
01/2007 - 01/2005
2estradiol 3-benzoate (estradiol benzoate)IBA
09/2003 - 07/2002
2Codon (Codons)IBA
09/2003 - 04/2003
1Thioctic Acid (Lipoic Acid)IBA
09/2013
1alpha-benzoylamino-1,4-naphthoquinone (PPM 18)IBA
07/2013
1Extracellular Matrix ProteinsIBA
03/2013
1Antithyroid Agents (Antithyroid Drugs)IBA
03/2013
1Calbindin 2IBA
10/2012
1ParvalbuminsIBA
10/2012
1gamma-Aminobutyric Acid (GABA)IBA
10/2012
1Cyclin-Dependent Kinase Inhibitor p16IBA
09/2012
1SMTP 7IBA
06/2012
1Hyaluronan ReceptorsIBA
06/2012

Therapy/Procedure

15Intraperitoneal Injections
01/2012 - 06/2002
4Ovariectomy (Oophorectomy)
02/2010 - 07/2002
3Hepatectomy
02/2010 - 08/2004
3Oral Administration
10/2009 - 08/2003
2Subcutaneous Injections
07/2009 - 04/2002